CRON vs PBH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CRON · Cronos Group$3.61 ▼ 2.96%
PBH · Prestige Consumer Healthcare$42.98 ▼ 3.02%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CRON +41.0%
- PBH -28.9%
Head to head
| Metric | CRON | PBH |
|---|---|---|
| Price | $3.61 | $42.98 |
| Change today | ▼ 2.96% | ▼ 3.02% |
| Market cap | $1.32B | $2.04B |
| Return, 3 months | +20.3% | -18.9% |
| Return, year to date | +37.3% | -30.3% |
| Return, 1 year | +45.6% | -28.3% |
| P/E (TTM) | 22.6 | 13.3 |
| P/B | 1.2 | 1.0 |
| P/E percentile vs own 5y | 86th | 33rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +58.4% | +6.5% |
| Net profit growth (YoY) | +192.7% | -38.5% |
| Gross margin | 45.9% | 53.5% |
| Operating margin | -2.9% | 26.3% |
| Net margin | 39.1% | 15.6% |
| Return on equity | 6.5% | 9.1% |
| Analyst target vs. price | +38.8% | +67.5% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 64 | 37 |
| 30-day volatility | 32.1% | 64.0% |
| Max drawdown, 1 year | -26.9% | -38.8% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PBH is the largest of the group by market value.
- CRON has returned the most over the past year.
- PBH carries the lowest trailing P/E.
- CRON is growing revenue fastest.
- CRON keeps the most profit per dollar of sales.
- CRON has been the calmest stock over the last 30 days.